Alnylam Pharmaceuticals, Inc.

Ownership Transactions Reported by 23 Insiders

Symbol
ALNY on Nasdaq
Location
675 West Kendall Street, Henri A. Termeer Square, Cambridge, MA

Insiders trading volume in the past year

Alnylam Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Phillip A. Sharp Director $73.4M -$7.63M -9.42% Jan 23, 2025
John Maraganore Chief Executive Officer, Director $42.8M Dec 21, 2021
Yvonne Greenstreet Chief Executive Officer, Director $23.6M -$14.1M -37.5% Feb 13, 2025
Jeffrey V. Poulton EVP, Chief Financial Officer $9.3M -$1.13M -10.8% Feb 13, 2025
D. E. I. Pyott Director $6.59M -$7.16M -52.1% Jun 24, 2024
Akshay Vaishnaw President $4.32M Aug 3, 2023
Pushkal Garg CMO & EVP Dev & Med Affairs $3.89M -$17.2M -81.6% Feb 13, 2025
Tolga Tanguler EVP, Chief Commercial Officer $3.85M -$817K -17.5% Nov 25, 2024
Michael W. Bonney Director $3.75M May 16, 2024
Kevin Fitzgerald CSO & EVP, Head of Research $3.48M -$7.53M -68.4% Feb 13, 2025
Robert W. Hesslein EVP, CLO and Secretary $2.03M Oct 1, 2024
Amy Schulman Director $2.02M -$5.26M -72.2% Jun 25, 2024
Laurie Keating EVP, Chief Legal Officer $1.03M Aug 5, 2021
Dennis Ausiello Director $969K -$5.31M -84.6% Aug 6, 2024
Indrani Franchini EVP, CLO & Secretary $915K -$51.1K -5.29% Feb 27, 2024
Steven M. Paul Director $185K Apr 1, 2022
Marsha Fanucci Director May 18, 2023
Peter N. Kellogg Director May 16, 2024
Olivier Brandicourt Director May 16, 2024
Margaret A. Hamburg Director May 16, 2024
Charles Elliott Sigal Director May 16, 2024
Colleen F. Reitan Director May 16, 2024
Carolyn R. Bertozzi Director May 16, 2024

Recent Insider Transactions by Companies or Individuals for Alnylam Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.